AGP Picks
View all

Today in Medicine: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Medicine.

Press releases published on November 13, 2026

CUKTECH Membuat Penampilan Sulung di MPL Malaysia S18 Playoffs, Membawa Kuasa Boleh Dipercayai dan Peak Performance ke Arena Esports
Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
COSCIENS Biopharma Inc. Reports Q3 2026 Results and Provides Update On Convertible Debenture Offering
Sol y Vida Recognizes National Diabetes Awareness Month, Honoring the Families and Communities Leading the Way on Early Detection
Lifeward Reports Third Quarter 2026 Financial Results and Provides Business Update
UPDATED -- Benitec Biopharma Releases First Quarter 2027 Fiscal-Year Financial Results and Provides Operational Update
Silexion Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Arcutis Presents New Caregiver-Reported Outcomes Data Supporting ZORYVE® (roflumilast) Cream 0.05% for Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months at the ACAAI Annual Scientific Meeting
NeOnc Showcases Two Brain Cancer Drug Programs at SNO as FDA Meetings Approach
Global 3D Printing Drugs Market to Reach $540.4 Million by 2031
Sienna Announces November Dividend
Vericel to Present at the Stephens Annual Investment Conference on Wednesday, November 18, 2026
 AIM ImmunoTech Approaches Major Clinical Inflection Point with Phase 2 Pancreatic Cancer Data Expected Q1 2027; Reports Third Quarter 2026 Financial Results
Wave Life Sciences Highlights WVE-007 (INHBE siRNA) Progress at ObesityWeek® 2026
SS Innovations Strengthens Management Team in Preparation for Global Sales Expansion
Kyntra Bio to Report Third Quarter 2026 Financial Results
InspireMD Announces Pricing of $37.5 Million Public Offering
Nanox Announces Distribution Agreement with Medworks for Nanox.AI in Greece
Allarity Therapeutics Reports Third Quarter 2026 Results and Provides Full Year 2026 Financial Guidance
Biofrontera Inc. Reports Strong Third Quarter 2026 Financial Results Driven by 30% Year-Over-Year Revenue Growth

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Medicine

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.